Rosiglitazone Maleate and Metformin HCl Articles

EMEA seeks expanded rosiglitazone warning

4 February 2008

TZD diabetes drugs to get black box warning

20 August 2007

GlaxoSmithKline sees flattish 2nd-qtr results, but sales helped by Advair

30 July 2007

Reaction to Avandia warnings stronger among internists than endocrinologists

23 July 2007

Texas family is first to sue GSK over Avandia

25 June 2007

Actos/Avandia get black box after Congress hears how GSK and FDA handled concerns

18 June 2007

GSK posts solid results for 1st-qtr 2007 with a 14% EPS rise despite US generic pressure

30 April 2007

GSK alerts US prescribers to Avandia problems

26 February 2007

GSK's Avandia delays deterioration of glucose control, five-year ADOPT data show

11 December 2006

DREAM study results position GSK's Avandia as first-line treatment for type 2 diabetes

25 September 2006

GlaxoSmithKline sees 2nd-qtr net leap 14% on strong, 11%, sales growth

31 July 2006

GSK 's Avandamet gets FDA approval for type 2 diabetes

17 July 2006

Novartis' Galvus overcomes poor glycemic control

19 June 2006

Merck/Novartis' DPP-4 inhibitors and Lilly's ruboxistaurin are stars of ADA 2006

19 June 2006

UPDATE: ABPI suspends Abbott Labs over hospitality, also raps GSK for breach of undertaking

20 February 2006

Abbott Laboratories suspended from ABPI

20 February 2006

GlaxoSmithKline's 7% sales growth and 18% EPS rise in line with expectations

13 February 2006

Metabolix' insulin sensitizer outperforms gold-standard therapies

30 January 2006

Japan stock market week to September 5

12 September 2005

GSK EPS rises 10% on 6% sales growth

8 August 2005

GlaxoSmithKline sees 10% EPS rise on 6% sales growth

1 August 2005

GSK's Paxil returns to US market

4 July 2005

Lehman Brothers boosts peak sales forecasts of GSK drugs after R&D review

27 June 2005

GSK resolves production problems with FDA; agrees increased royalties with SkyePharma

9 May 2005

GSK to resume Paxil/Avandamet production in Puerto Rico?

28 April 2005

Study shows genes predict how well diabetes drug will work

26 April 2005

GSK updates on US drug seizures

11 April 2005

FDA halts distribution of two GSK drugs

14 March 2005

Turnaround for GSK as generic woes abate, future looks bright with sturdy pipeline

21 February 2005

SCOLR Pharma files provisional patent for rosiglitazone

10 January 2005

GlaxoSmithKline's profit drops again for 3rd qtr, on flagging sales and weak dollar

8 November 2004

EC OKs new dosage strengths of GSK's Avandamet

20 September 2004

GSK results in line with company guidance; shares fall on 16% drop in 4th-qtr income

23 February 2004

Stock Commentary - Europe

19 January 2004

Tokyo pharma stocks - week to Jan 12

19 January 2004

EU approval for GSK's Avandamet

3 November 2003

GlaxoSmithKline reports 24% 3rd qtr earnings growth

27 October 2003

GSK 2nd-qtr earnings beat forecasts

28 July 2003

GSK drops Avandia deal with B-MS

12 August 2002

Showing 1-39 of 39 articles

Go to beginningPrevious
  • 1
NextGo to end